Cambrex completes $24M API manufacturing facility; Twist and LakePharma partner on antibody contract work
→ Cambrex Corporation $CBM completed its $24 million API (HPAPI) manufacturing facility at its site in Charles City, IA. The facility is undergoing validation and is expected to be ready to start customer projects in May.
→ PDL BioPharma is investing up to $60 million into Evofem Biosciences. PDL is investing alongside two existing Evofem shareholders, which have the right to invest up to $10 million each. The money will be used to back their pre-commercial activities for Amphora, its contraceptive gel for women.
→ Twist Bioscience and LakePharma announced a strategic collaboration to offer antibody discovery and development solutions to pharmaceutical and biotechnology customers.